Nian Wu, Ph.D.
Chief Executive Officer

Founder and lead inventor of the Liposeuticals technology platform, Dr. Nian Wu has over 30 years of experience in pharmaceutical product R&D, product formulation and project management. He was formerly a Research Faculty and Group Head from 2004 to 2013 at Memorial Sloan-Kettering Cancer Center (MSKCC) and adjunct professor at Gerstner Sloan-Kettering Graduate School of Biomedical Sciences in New York City, and prior to that worked at Schering-Plough (now Merck & Co.), Wyeth-Ayerst (now Pfizer), and Alpharma (also now part of Pfizer). He has published over 60 research articles and is listed as an inventor or co-inventor on over 20 patents. He earned a master degree in chemistry from the University of Scranton in Scranton, PA, obtained his Ph.D. in chemistry from the State University of New York and did his postdoctoral work in the University of Illinois at Urbana-Champaign.

Yan Liu, MSc, MBA
Sr. Advisor, Business Strategy

Ms. Liu has strong leadership experience in global clinical development and business development through her contributions to Allergan, Sanofi-Aventis, Eisai, Synergy Pharmaceuticals, Mankind, Target Health and Yuanxing Gene Technology Co. Her broad drug development expertise at biostatistics and clinical trial management across CNS, oncology, cardiovascular and rare diseases areas. Her depth of experience and expertise includes contract manufacturing (CMO) and comprehensive project management/portfolio management/in- or out-licensing with demonstrated success in partnerships strategies resulted in millions dollars revenue stream. She has consummated several in and out licensing deals which generated more than billion dollars. She was a key management member in decision making in specialty pharmaceutical companies. She has worked with a number of small and large pharmas. Yan graduated with a master degree in Master of Statistics from University of Ottawa and MBA from Kellogg School of Management at Northwestern University.

James Liu, Ph.D.
Vice President

Dr. Liu has served as our Vice President of Product Development since November 2018 and leads the product development of our CNS and Oncology programs. He has over 25 years of experience in pharmaceutical R&D. Before joining LipoSeuticals, Dr. Liu conducted drug research and development at Schering-Plough, Merck and BMS. He was responsible for the development of medicines in multiple therapeutic areas, including CNS, oncology and hepatitis C infection. Dr. Liu is author or co-author of over 30 articles in top peer viewed journals and he received her Ph.D. degree in chemistry from the State University of New York.

Chris Ye, Ph.D.
Senior Principal Scientist

Dr. Ye has more than 20 years’ experience in the field of chemistry and pharmaceuticals. Dr. Ye has a broad background and knowledge in multi-step organic synthesis, process optimization/ scale up synthesis. Expertise in synthesis of heterocyclic compounds, boronic acids and fluorine chemistry. He has been working in prestigious institution and various pharmaceutical and chemical industries. Dr. Ye obtained his Ph. D. in chemistry from Chinese Academy of Sciences and had his postdoctoral training at University of Idaho. Dr. Ye co-authored 10 articles in top peer viewed journals. Dr. Ye is the key person and serves as a technical director for the sugar-lipid polymer production.

Lan-Bo Chen, Ph.D.
Board Director and Scientific Advisor

Dr. Chen is Professor Emeritus of Pathology at Harvard Medical School. He received his Ph.D. in cell biology from the Massachusetts Institute of Technology and elected as an academician of the Academia Sinica of Taiwan. He is the author of over 250 academic publications and is the founder of several successful biotechnology companies and ventures, including Fuji ImmunoPharmaceuticals Corp. and Shionogi BioResearch Corp. (both with Nobel laureate Dr. Susumu Tonegawa); Caxton Life Science Partners; Taiwan Global BioFund; TaiMed Biologics; Mevion Medical Systems; Cancer BioScience; Cancer Genetics; Kava Pharmaceuticals; SinglePixel BioMedical; Quercegen Pharma; Madrigal/Synta Pharmaceuticals and Sequential Medicine. Dr. Chen has served as a Senior Consultant for numerous large pharmaceutical firms, and has led the development or consulted for more than a dozen drugs and drug candidates.

Joseph Vinson, Ph.D.
Board Director and Scientific Advisor

Dr. Vinson is Professor Emeritus of Chemistry at University of Scranton. He received his Ph.D. in Chemistry from the Iowa State University. His research has been featured in Prevention, Psychology Today, Consumer Reports, AARP, Tufts Health & Nutrition Newsletter, US News & World Report and lam pooned in a cartoon in Time magazine. He has appeared on TV-Good Morning America Sunday and radio-NPR “All Things Considered” and “The Peoples Pharmacy,” as well as being mentioned by Jay Leno and Rush Limbaugh. Dr. Vinson is the author of over 70 publications. His research interests are wide-ranging and include drug analysis in physiological fluids and the effect of vitamins, minerals, and antioxidants on nutrition and health.